Rare diseases
Investigational molecules
Locations
Haartmaninkatu 4, 00290 Helsinki, Finland
Clinical research activity is centered on reversible cerebral vasoconstriction syndrome, with attention to acute neurological symptoms and recurrent headache patterns.
The sponsor’s trial activity reflects a focused interest in cerebrovascular disorders affecting patients without major structural findings on CT or MRI.
HUS Helsinki University Hospital runs clinical trials in conditions such as Reversible cerebral vasoconstriction syndrome, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FinlandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
